HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Qian Selected Research

Motilin

8/2015Therapeutic effects of Lactobacillus casei Qian treatment in activated carbon-induced constipated mice.
1/2015Preventive effect of Lactobacillus fermentum Lee on activated carbon-induced constipation in mice.
1/2015Preventive Effect of Lactobacillus fermentum Zhao on Activated Carbon-Induced Constipation in Mice.
11/2014Therapeutic effect of activated carbon-induced constipation mice with Lactobacillus fermentum Suo on treatment.
7/2013Preventive effect of resistant starch on activated carbon-induced constipation in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Qian Research Topics

Disease

57Neoplasms (Cancer)
11/2022 - 01/2012
13Inflammation (Inflammations)
01/2021 - 03/2013
11Bone Resorption
07/2021 - 05/2016
10Neoplasm Metastasis (Metastasis)
06/2021 - 01/2012
9Constipation
12/2019 - 07/2013
8Body Weight (Weight, Body)
01/2021 - 10/2013
6Chronic Hepatitis B
02/2022 - 12/2018
6Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2014
6Osteoporosis
07/2021 - 10/2016
6Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2017
6Carcinoma (Carcinomatosis)
01/2020 - 03/2013
6Carcinogenesis
01/2019 - 01/2014
5Osteoarthritis
01/2021 - 10/2019
5Esophageal Squamous Cell Carcinoma
10/2020 - 01/2016
5Wounds and Injuries (Trauma)
11/2018 - 05/2011
5Osteosarcoma (Osteogenic Sarcoma)
08/2017 - 01/2013
4Glioma (Gliomas)
06/2022 - 01/2015
4Stroke (Strokes)
01/2022 - 01/2020
4Lymphatic Metastasis
06/2021 - 01/2014
4Pain (Aches)
03/2021 - 01/2018
4Necrosis
01/2014 - 05/2013
3Colonic Neoplasms (Colon Cancer)
11/2022 - 01/2014
3Rheumatoid Arthritis
01/2022 - 01/2021
3Ischemic Stroke
01/2022 - 01/2020
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2020
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2021 - 03/2013
3Breast Neoplasms (Breast Cancer)
07/2021 - 10/2018
3Cancer Pain
03/2021 - 06/2019
3Fibrosis (Cirrhosis)
01/2021 - 01/2019
3Brain Edema (Cerebral Edema)
10/2020 - 12/2017
3Traumatic Brain Injuries (Traumatic Brain Injury)
10/2020 - 01/2018
3Bone Diseases (Bone Disease)
01/2019 - 10/2018
2Liver Failure
02/2022 - 01/2019
2Diabetes Mellitus
01/2022 - 12/2020
2Neuroinflammatory Diseases
01/2022 - 01/2018
2Non-alcoholic Fatty Liver Disease
01/2022 - 01/2021
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2021 - 01/2021
2Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
06/2021 - 01/2019
2Infections
01/2021 - 03/2016
2COVID-19
01/2021 - 10/2020
2Leukemia
01/2021 - 01/2021
2Cognitive Dysfunction
01/2021 - 01/2019
2Liver Cirrhosis (Hepatic Cirrhosis)
12/2020 - 01/2020
2Cerebral Hemorrhage
12/2020 - 10/2019

Drug/Important Bio-Agent (IBA)

12Messenger RNA (mRNA)IBA
06/2022 - 03/2013
10CytokinesIBA
11/2022 - 05/2013
9Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2014
9Pharmaceutical PreparationsIBA
01/2022 - 01/2012
8CarbonIBA
01/2019 - 07/2013
8TeaIBA
11/2018 - 08/2013
7Interleukin-6 (Interleukin 6)IBA
11/2022 - 01/2012
7LipopolysaccharidesIBA
01/2021 - 01/2019
6Matrix Metalloproteinases (MMPs)IBA
02/2016 - 03/2013
5Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2018
5Biological ProductsIBA
01/2022 - 02/2016
5CateninsIBA
10/2020 - 06/2012
5Dextran SulfateIBA
10/2018 - 03/2013
5GastrinsIBA
08/2015 - 07/2013
5Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
08/2015 - 07/2013
5Endothelins (Endothelin)IBA
08/2015 - 07/2013
5AcetylcholinesteraseIBA
08/2015 - 07/2013
5Substance PIBA
08/2015 - 07/2013
5MotilinIBA
08/2015 - 07/2013
5Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
08/2015 - 07/2013
5BromidesIBA
10/2014 - 03/2013
5Caspase 3 (Caspase-3)IBA
10/2014 - 06/2012
4InterleukinsIBA
11/2022 - 10/2013
4LigandsIBA
07/2021 - 01/2019
4Opioid Analgesics (Opioids)IBA
03/2021 - 12/2018
4MicroRNAs (MicroRNA)IBA
01/2021 - 01/2013
4Ethanol (Ethyl Alcohol)IBA
10/2019 - 03/2016
4Therapeutic UsesIBA
01/2019 - 05/2011
3InterferonsIBA
01/2022 - 11/2018
3Peptides (Polypeptides)IBA
01/2022 - 09/2012
3NucleotidesIBA
01/2022 - 01/2015
3salicylhydroxamic acid (SHAM)IBA
06/2021 - 01/2021
3EnzymesIBA
01/2021 - 12/2015
3galanginIBA
01/2021 - 01/2017
3garcinolIBA
01/2020 - 01/2019
3AntigensIBA
01/2020 - 01/2016
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2019 - 10/2018
3CurcuminIBA
05/2016 - 01/2014
3Caspase 9IBA
10/2014 - 03/2013
3Metalloproteases (Metalloproteinases)IBA
10/2014 - 03/2013
3Resistant StarchIBA
01/2014 - 07/2013
2CarcinogensIBA
06/2022 - 04/2013
2GlucocorticoidsIBA
02/2022 - 01/2019
2HydrogelsIBA
02/2022 - 05/2016
2Phosphotransferases (Kinase)IBA
01/2022 - 01/2017
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2022 - 11/2020
2AlbuminsIBA
01/2022 - 10/2018
2NADP (NADPH)IBA
01/2022 - 01/2021
2human ERBB2 proteinIBA
07/2021 - 06/2021
2RNA (Ribonucleic Acid)IBA
04/2021 - 01/2019
2Morphine (MS Contin)FDA LinkGeneric
03/2021 - 01/2020
2Cyclin D2IBA
01/2021 - 12/2020

Therapy/Procedure

16Therapeutics
02/2022 - 10/2013
4Drug Therapy (Chemotherapy)
01/2022 - 01/2015
3Immunotherapy
01/2020 - 01/2018
3Palliative Care (Palliative Therapy)
01/2020 - 12/2018